An improved whole cell pertussis vaccine with reduced content of endotoxin

Monocyte Activation Test (MAT) reliably detects pyrogens in parenteral formulations of human serum albumin

(2014) Rolando Perdomo-Morales   ALTEX-Alternatives to Animal Experimentation

Global, regional, and national causes of child mortality in 2008: a systematic analysis

(2010) Robert E Black et al.   LANCET

Pertussis vaccines: WHO position paper—Recommendations

(2010) WHO Publication   VACCINE

Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants

(2009) T. Q. Zorzeto et al.   Clinical and Vaccine Immunology

Reducing variation in a rabbit vaccine safety study with particular emphasis on housing conditions and handling

(2009) Cynthia M Verwer et al.   LABORATORY ANIMALS

Acellular and "low" pertussis vaccines: adverse events and the role of mutations

(2009) Hisako G. Higashi et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice

(2009) Wagner Quintilio et al.   VACCINE

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b

(2008) Reinaldo de Menezes Martins et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Reactogenicity of infant whole cell pertussis combination vaccine compared with acellular pertussis vaccines with or without simultaneous pneumococcal vaccine in the Netherlands

(2008) Silke David et al.   VACCINE

Supplementation of whole-cell pertussis vaccines with lipopolysaccharide analogs: Modification of vaccine-induced immune responses

(2008) Jeroen Geurtsen et al.   VACCINE

Improving the cellular pertussis vaccine: Increased potency and consistency

(2007) Marcel Thalen et al.   VACCINE